Skip to main content
. 2026 Sep 3;14(9):773. doi: 10.3390/vaccines14090773
AE Adverse event
AESI Adverse event of special interest
CONSORT Consolidated Standards of Reporting Trials
GBS Guillain–Barré syndrome
GMFR Geometric mean fold rise
GMT Geometric mean titer
LLOQ Lower limit of quantitation
LRTI Lower respiratory tract illness
NDCMC Newly diagnosed chronic medical condition
RSV Respiratory syncytial virus
RSVpreF Respiratory syncytial virus prefusion F protein vaccine
SAE Serious adverse event